About
Introduction
As a molecular biologist, Karin is interested in the clinical potential of alterations in molecular processes in solid organ transplantation. She focusses on the role of variations in DNA methylation in post-transplant complications such as rejection as well as the development of malignancies. Moreover she investigates the clinical value of minimally invasive markers such as donor-derived cell-free DNA, circulating nucleosomes and extracellular vesicles in the diagnosis of rejection.
